OrbusNeich Medical Group Holdings Limited Statistics
Want to see HK:6929 full AI Analyst Report?
OrbusNeich Medical Group Holdings Limited (6929) Stock Statistics & Valuation Metrics
Total Valuation
OrbusNeich Medical Group Holdings Limited has a market cap or net worth of HKD 3.03B. The enterprise value is HKD 1.72B.
- Market Cap
- HKD 3.03B
- Enterprise Value
- HKD 1.72B
Share Statistics
OrbusNeich Medical Group Holdings Limited has 827,968,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 827,968,300
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
OrbusNeich Medical Group Holdings Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 8.37%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.09
- Return on Invested Capital (ROIC)
- 8.37%
- Return on Capital Employed (ROCE)
- 0.09
- Revenue Per Employee
- 118.10K
- Profits Per Employee
- 27.42K
- Employee Count
- 1,528
- Asset Turnover
- 0.40
- Inventory Turnover
- 0.86
Valuation Ratios
The current PE Ratio of OrbusNeich Medical Group Holdings Limited is 8.74. OrbusNeich Medical Group Holdings Limited’s PEG ratio is 1.03.
- PE Ratio
- 8.74
- PS Ratio
- 1.97
- PB Ratio
- 0.92
- Price to FCF
- 15.64
- Price to Operating Cash Flow
- 8.08
- PEG Ratio
- 1.03
Income Statement
In the last 12 months, OrbusNeich Medical Group Holdings Limited had revenue of 180.45M and earned 41.90M in profits. Earnings per share was 0.05.
- Revenue
- 180.45M
- Gross Profit
- 122.43M
- Operating Income
- 39.74M
- Pretax Income
- 47.09M
- Net Income
- 41.90M
- EBITDA
- 45.56M
- Earnings Per Share (EPS)
- 0.05
Cash Flow
In the last 12 months, operating cash flow was 47.73M and capital expenditures -23.07M, giving a free cash flow of 24.66M billion.
- Operating Cash Flow
- 47.73M
- Free Cash Flow
- 24.66M
- Free Cash Flow per Share
- 0.03
Dividends & Yields
OrbusNeich Medical Group Holdings Limited pays an annual dividend of HKD 0.15, resulting in a dividend yield of 5.43%
- Dividend Per Share
- HKD 0.15
- Dividend Yield
- 5.43%
- Payout Ratio
- 26.07%
- Free Cash Flow Yield
- 6.39%
- Earnings Yield
- 11.31%
Stock Price Statistics
- Beta
- 0.33
- 52-Week Price Change
- -14.14%
- 50-Day Moving Average
- 3.74
- 200-Day Moving Average
- 3.73
- Relative Strength Index (RSI)
- 43.42
- Average Volume (3m)
- 67.52K
Important Dates
OrbusNeich Medical Group Holdings Limited upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Mar 11, 2027
- Ex-Dividend Date
- Sep 18, 2025
Financial Position
OrbusNeich Medical Group Holdings Limited as a current ratio of 10.54, with Debt / Equity ratio of 0.95%
- Current Ratio
- 10.54
- Quick Ratio
- 8.51
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -4.71
- Interest Coverage Ratio
- 236.54
Taxes
In the past 12 months, OrbusNeich Medical Group Holdings Limited has paid 5.05M in taxes.
- Income Tax
- 5.05M
- Effective Tax Rate
- 0.11
Enterprise Valuation
OrbusNeich Medical Group Holdings Limited EV to EBITDA ratio is 3.71, with an EV/FCF ratio of 7.83.
- EV to Sales
- 0.99
- EV to EBITDA
- 3.71
- EV to Free Cash Flow
- 7.83
- EV to Operating Cash Flow
- 4.05
Balance Sheet
OrbusNeich Medical Group Holdings Limited has HKD 199.23M in cash and marketable securities with HKD 6.77M in debt, giving a net cash position of HKD 192.46M billion.
- Cash & Marketable Securities
- HKD 199.23M
- Total Debt
- HKD 6.77M
- Net Cash
- HKD 192.46M
- Net Cash Per Share
- HKD 0.23
- Tangible Book Value Per Share
- HKD 0.48
Margins
Gross margin is 68.60%, with operating margin of 22.64%, and net profit margin of 22.33%.
- Gross Margin
- 68.60%
- Operating Margin
- 22.64%
- Pretax Margin
- 25.83%
- Net Profit Margin
- 22.33%
- EBITDA Margin
- 26.63%
- EBIT Margin
- 23.01%
Analyst Forecast
The average price target for OrbusNeich Medical Group Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 16.25%
- EPS Growth Forecast
- 7.80%
Scores
- Smart Score
- 5
- AI Score
- 78

